로딩 중…
지수 로딩 중…
Mezzion Pharma Co.,Ltd.
140410· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩61,600-2.84%
2026-06-19
Price Chart
Mezzion Pharma Co.,Ltd.+49.88%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 1.87T KRW |
| Revenue | 7.97B KRW |
| Net Income | -26.64B KRW |
| Total Assets | 98.92B KRW |
| Net Assets | 15.51B KRW |
| Employees | 18 |
| Value | |
| P/B | 120.70x |
| P/S | 234.85x |
| FCF Yield | -0.89% |
| Profitability | |
| ROE | -171.75% |
| ROA | -26.93% |
| Op. Margin | -223.45% |
| Revenue Growth | 3.19% |
| Financial Health | |
| Debt Ratio | 637.75% |
| Total Debt | 10.56B KRW |
| FCF | -16.73B KRW |
| Cash | 17.42B KRW |
| Current Ratio | 0.47x |
| Performance | |
| 1Y Return | 49.88% |
| 1M Return | -11.87% |
| From 52W High | -65.76% |
| 1Y MDD | -65.55% |
| Trading | |
| Volume | 112,917 shares |
| Foreign Own. | 25.31% |
| Per Share | |
| EPS | -1,222 KRW |
| BPS | 510 KRW |
Company Info
CEO 박동현
Employees 18
Founded 2002
HQ 서울특별시 강남구, KR
Mezzion, established in 2002, is a KOSDAQ-listed pharmaceutical manufacturing and sales corporation. The company develops various new drugs, including treatments for erectile dysfunction and benign prostatic hyperplasia, and has licensed out and exported products to major countries such as the United States. Recently, Mezzion has focused on developing a single ventricle disease treatment, having received FDA approval for an additional clinical protocol in 2023 and currently proceeding with further clinical trials. The company is headquartered in Gangnam-gu, Seoul.